Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Sym-023 by Les Laboratoires Servier for Metastatic Bile Duct Cancer: Likelihood of Approval
Sym-023 is under clinical development by Les Laboratoires Servier and currently in Phase I for Metastatic Bile Duct Cancer. According...
Data Insights
Sym-023 by Les Laboratoires Servier for Lymphoma: Likelihood of Approval
Sym-023 is under clinical development by Les Laboratoires Servier and currently in Phase I for Lymphoma. According to GlobalData, Phase...